Cargando…
Association between matrix metalloproteinase‐9 and worsening heart failure events in patients with chronic heart failure
AIMS: Matrix metalloproteinase (MMP) is up‐regulated during heart failure (HF) and influences ventricular remodeling. We hypothesized that disparity between MMP‐9 and tissue inhibitors of MMP‐1 (TIMP‐1) results in clinical manifestations and is related to prognostic risk in patients with chronic HF....
Autores principales: | Morishita, Tetsuji, Uzui, Hiroyasu, Mitsuke, Yasuhiko, Amaya, Naoki, Kaseno, Kenichi, Ishida, Kentaro, Fukuoka, Yoshitomo, Ikeda, Hiroyuki, Tama, Naoki, Yamazaki, Taketoshi, Lee, Jong‐Dae, Tada, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542740/ https://www.ncbi.nlm.nih.gov/pubmed/28772055 http://dx.doi.org/10.1002/ehf2.12137 |
Ejemplares similares
-
Sequential organ failure assessment score on admission predicts long‐term mortality in acute heart failure patients
por: Aoyama, Daisetsu, et al.
Publicado: (2020) -
Predictive Utility of the Changes in Matrix Metalloproteinase‐2 in the Early Phase for Left Ventricular Reverse Remodeling After an Acute Myocardial Infarction
por: Morishita, Tetsuji, et al.
Publicado: (2015) -
Effects of Sitagliptin on the Coronary Flow Reserve, Circulating Endothelial Progenitor Cells and Stromal Cell-derived Factor-1alpha
por: Morishita, Tetsuji, et al.
Publicado: (2019) -
Association between Changes in the Systolic Blood Pressure from Evening to the Next Morning and Night Glucose Variability in Heart Disease Patients
por: Shimizu, Tomohiro, et al.
Publicado: (2021) -
Effects of PCSK9 Inhibitor on Favorable Limb Outcomes in Patients with Chronic Limb-Threatening Ischemia
por: Sato, Yusuke, et al.
Publicado: (2021)